Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Dysregulating the mitochondrial caseinolytic protease P (hClpP) for combating acute myeloid leukaemia
EF 2020-21
Résumé
Proteins are large biological molecules that perform many of the critical functions in cells. Often these proteins are organized as molecular machines and, like their macroscopic counterparts, these machines work through a series of moving parts. Only through an understanding of how these parts move and how their motion is related to function can these molecular machines be manipulated to potentially cure disease. One critically important molecular machine, called human mitochondrial caseinolytic protease P, or hClpP, is involved in maintaining the health of mitochondria, the powerhouse of the cell. Previous studies have shown that hClpP is essential for the survival of leukaemia cells and have established that hClpP is an important target in the fight against blood cancers. Although three-dimensional pictures of hClpP are available, there is little information about how the molecule changes its structure in time, limiting rational attempts to modulate its function so as to kill leukaemia cells. I propose to study hClpP using a number of different biophysical techniques, including NMR spectroscopy and cryo-electron microscopy, which will allow me to obtain movies of how this molecule works in solution and how it interacts with existing small-molecule activators and inhibitors. This will allow me to trace how different parts of the molecule communicate for function. With this understanding it may become possible to modulate hClpP function by developing new small molecules targeting it, leading to novel therapies against blood cancers.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
449801
Name
Sever Alexander I
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Dysregulating the mitochondrial caseinolytic protease P (hClpP) for combating acute myeloid leukaemia
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Acute Myeloid Leukaemia; Dynamics; Electron Cryo-Microscopy; Mitochondrial Caseinolytic Protease P; Nuclear Magnetic Resonance
Abstract
Proteins are large biological molecules that perform many of the critical functions in cells. Often these proteins are organized as molecular machines and, like their macroscopic counterparts, these machines work through a series of moving parts. Only through an understanding of how these parts move and how their motion is related to function can these molecular machines be manipulated to potentially cure disease. One critically important molecular machine, called human mitochondrial caseinolytic protease P, or hClpP, is involved in maintaining the health of mitochondria, the powerhouse of the cell. Previous studies have shown that hClpP is essential for the survival of leukaemia cells and have established that hClpP is an important target in the fight against blood cancers. Although three-dimensional pictures of hClpP are available, there is little information about how the molecule changes its structure in time, limiting rational attempts to modulate its function so as to kill leukaemia cells. I propose to study hClpP using a number of different biophysical techniques, including NMR spectroscopy and cryo-electron microscopy, which will allow me to obtain movies of how this molecule works in solution and how it interacts with existing small-molecule activators and inhibitors. This will allow me to trace how different parts of the molecule communicate for function. With this understanding it may become possible to modulate hClpP function by developing new small molecules targeting it, leading to novel therapies against blood cancers.
Competitiondate
202012
Approvedterm2
1 yr 0 mth
Pinamesdelim
Sever, Alexander I
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~